Perhexiline
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01074 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 45 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | hypertrichosis (disease) | KG + DL |
| 4 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 5 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 6 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 7 | isolated genetic hair shaft abnormality | KG + DL |
| 8 | oral candidiasis | KG + DL |
| 9 | headache disorder | KG + DL |
| 10 | leprosy | KG + DL |
| 11 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 12 | migraine with or without aura, susceptibility to | KG + DL |
| 13 | trigeminal autonomic cephalalgia | KG + DL |
| 14 | commissural lip fistula | KG + DL |
| 15 | osteoradionecrosis of the mandible | KG + DL |
| 16 | oral leukoedema | KG + DL |
| 17 | burning mouth syndrome | KG + DL |
| 18 | benign prostatic hyperplasia (disease) | KG + DL |
| 19 | pulmonary hypertension | KG + DL |
| 20 | atrophoderma vermiculata | KG + DL |
| 21 | female breast carcinoma | KG + DL |
| 22 | mycotic corneal ulcer | KG + DL |
| 23 | kyphoscoliotic heart disease | KG + DL |
| 24 | ulerythema ophryogenesis | KG + DL |
| 25 | Prinzmetal angina | KG + DL |
| 26 | candidiasis | KG + DL |
| 27 | common cold | KG + DL |
| 28 | breast fibrocystic disease | KG + DL |
| 29 | prostate calculus | KG + DL |
| 30 | open-angle glaucoma | KG + DL |
| 31 | hyperthyroidism | KG + DL |
| 32 | primary hereditary glaucoma | KG + DL |
| 33 | blunt duct adenosis of breast | KG + DL |
| 34 | apocrine adenosis of breast | KG + DL |
| 35 | peripheral vascular disease | KG + DL |
| 36 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 37 | persistent Mullerian duct syndrome | KG + DL |
| 38 | lymphocytic hypereosinophilic syndrome | KG + DL |
| 39 | prostate neoplasm | KG + DL |
| 40 | collagenopathy | KG + DL |
| 41 | benign mammary dysplasia | KG + DL |
| 42 | renin-angiotensin-aldosterone system-blocker-induced angioedema | KG + DL |
| 43 | herpes simplex virus keratitis | KG + DL |
| 44 | genetic alopecia | KG + DL |
| 45 | familial isolated trichomegaly | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.